SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 244 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,988,628 | +33082.5% | 54,889 | -67.3% | 0.01% | -68.2% |
| Q4 2022 | $5,993 | -99.6% | 168,010 | +298.0% | 0.02% | +340.0% |
| Q3 2022 | $1,429,000 | +17.0% | 42,215 | 0.0% | 0.01% | 0.0% |
| Q2 2022 | $1,221,000 | -39.6% | 42,215 | -39.2% | 0.01% | -16.7% |
| Q4 2021 | $2,023,000 | +807.2% | 69,389 | +935.3% | 0.01% | +100.0% |
| Q4 2018 | $223,000 | – | 6,702 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 699,432 | $35,216,000 | 4.25% |
| Provident Investment Management, Inc. | 590,269 | $29,720,000 | 4.23% |
| CAPITAL MANAGEMENT CORP /VA | 225,232 | $11,340,000 | 2.90% |
| FALCON POINT CAPITAL, LLC | 188,341 | $9,483,000 | 2.04% |
| Ranger Investment Management | 600,464 | $30,233,000 | 2.00% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 471,260 | $23,728,000 | 1.96% |
| KOPP INVESTMENT ADVISORS LLC | 41,700 | $2,100,000 | 1.77% |
| SHAKER INVESTMENTS LLC/OH | 49,617 | $2,498,000 | 1.54% |
| Bruce & Co., Inc. | 148,058 | $7,454,000 | 1.44% |
| Bridge City Capital, LLC | 45,843 | $2,308,000 | 1.43% |